ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma
Abstract Background Lung adenocarcinoma (LUAD) is a common subtype of non‐small cell lung cancer with high morbidity and mortality rates and is usually detected at advanced stages because of the early onset of metastasis. Adenosine deaminase RNA‐specific 1 (ADAR1) is an RNA editing enzyme that catal...
Main Authors: | Wendi Yang, Kehong Chen, Qian Yu, Rongxin Liao, Hengqiu He, Yuan Peng, Zhenzhou Yang, Xiaoyue Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-07-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6044 |
Similar Items
-
Expression and clinical significance of adenosine deaminase acting on RNA-1 in lung adenocarcinoma
by: YANG Wendi, et al.
Published: (2021-12-01) -
Analysis of lymph node spread and its prognostic significance in ampullary adenocarcinoma: A retrospective study
by: Zheng-Yun Zhang, et al.
Published: (2022-08-01) -
The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas
by: Dincer Aydin, et al.
Published: (2023-08-01) -
Inguinal lymphadenopathy secondary to adenocarcinoma of caecum: A case report
by: Hakeem Abdul, et al.
Published: (2009-03-01) -
The Site of Lymph Node Metastasis: A Significant Prognostic Factor in Pancreatic Ductal Adenocarcinoma
by: Anil AYSAL, et al.
Published: (2022-09-01)